SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055661
Filing Date
2024-05-08
Accepted
2024-05-08 16:11:16
Documents
104
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnkd-20240331.htm   iXBRL 10-Q 2432356
2 EX-31.1 mnkd-ex31_1.htm EX-31.1 13644
3 EX-31.2 mnkd-ex31_2.htm EX-31.2 13643
4 EX-32.1 mnkd-ex32_1.htm EX-32.1 9650
5 EX-32.2 mnkd-ex32_2.htm EX-32.2 9662
  Complete submission text file 0000950170-24-055661.txt   13035944

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20240331.xsd EX-101.SCH 2328442
108 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20240331_htm.xml XML 2296954
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 24926136
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)